Inventor · disambiguated record
Spencer Liang
Also filed as: LIANG SPENCER · LIANG SPENCER C
18 granted patents·16 pending applications·55 citations·filing 2007–2025
93Inventor score
Top patents by PatentIndex Score
34 records- 0195US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0294US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0394US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 0493US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 0592US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 0692US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 0791US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 0890US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 0987US11225523B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2018·Granted Jan 18, 2022·3 cites·11 claims
- 1084US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 1183US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 1281US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1380US2025136710A1Triple combination antibody therapiesCOMPUGEN LTD·Filed 2024·Application pending·0 cites
- 1479US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1578US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 1675US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 1774US12152084B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2021·Granted Nov 26, 2024·0 cites·12 claims
- 1874US2024287204A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 1973US11655297B2ILDR2 antagonists and combinations thereofBAYER AG·Filed 2018·Granted May 23, 2023·1 cites·18 claims
- 2070US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 2170US2024279305A1SIGLEC-9 ECD Fusion Molecules and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 2268US10351625B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2018·Granted Jul 16, 2019·0 cites·34 claims
- 2363US11987612B2Siglec-9 ECD fusion moleculesALECTOR LLC·Filed 2020·Granted May 21, 2024·0 cites·20 claims
- 2462US11897968B2Anti-MerTK antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 13, 2024·0 cites·23 claims
- 2561US2024279341A1Bispecific anti-mertk and anti-pdl1 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2661US2024279358A1Monovalent anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2760US2025333523A1Anti-IL18 Binding Protein Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 2857US2024425587A1Pilra antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2954US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 3053US2008031882A1Methods of modulating IL-22 and IL-17LIANG SPENCER C·Filed 2007·Application pending·0 cites
- 3149US2022169736A1Combinations of anti-ildr2 antibodies and pd-1 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 3248US2008241130A1Methods and compositions for modulating il-17f/il-17a biological activityWRIGHT JILL F·Filed 2008·Application pending·0 cites
- 3348US2023220074A1Pilra antibodies and methods of use thereofALECTOR LLC·Filed 2021·Application pending·0 cites
- 3445US2011212099A1Methods of modulating il-22 and il-17WYETH LLC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Spencer Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →